At a Glance
- THA resulted in fewer complications and reoperations than ORIF in adults aged 40 to 49.
- Fracture pattern, timing of presentation, and surgeon experience influenced treatment selection.
- Limited follow-up left questions about the long-term durability of THA in younger patients.
Estimated reading time: 6 minutes
When a “young” hip fracture patient is in their 40s, the treatment decision becomes anything but straightforward. For orthopaedic surgeons, the choice between preserving the native joint or replacing it entirely can hinge on a complex mix of timing, fracture type, surgical expertise, and patient-specific factors.
In a recent interview with AAOS Now Editorial Board member Stuart Green, MD, FAAOS, Colin Cantrell, MD, discussed findings from a multicenter study examining outcomes of total hip arthroplasty (THA) versus open reduction internal fixation (ORIF) in adults aged 40 to 49 — a group that sits squarely in a treatment gray zone where the aforementioned factors may influence whether surgeons choose ORIF or THA.
Dr. Cantrell, an orthopaedic traumatologist at the University of Louisville, became interested in the topic during his fellowship experience, where he encountered numerous patients “on the borderline age range” between treatment pathways. “Do you start thinking about arthroplasty for femoral neck fracture, or do you fix it?” he recalled asking. Each case seemed highly individualized, shaped by factors such as fracture pattern, timing of presentation, and surgeon preference. This clinical ambiguity prompted a broader question: How do these patients fare over the long term depending on the treatment they receive?
Arthroplasty associated with fewer complications and reoperations
To investigate, Dr. Cantrell and his colleagues conducted a retrospective study across six Level I trauma centers. They reviewed a 10-year cohort of patients aged 40 to 49 who sustained femoral neck fractures, tracking treatment choice and outcomes. The study included 92 patients, of whom 70 underwent ORIF and 22 underwent THA. Mean follow-up was 75.5 weeks, although patients were only required to have a minimum of 12 weeks of follow-up for inclusion.
The findings revealed a striking contrast. Patients who underwent total hip arthroplasty experienced “much less reoperation and a lower complication rate” compared to those treated with internal fixation. In the arthroplasty group, only one patient experienced a periprosthetic fracture, and three developed heterotopic ossification (HO) that did not require surgical removal.
By comparison, the ORIF group presented a paradox. Although 75% of cases achieved what surgeons would consider an “excellent” anatomical reduction — meaning the fractured bone fragments were well aligned after surgery — the group still exhibited a complication rate exceeding 30%. This disconnect between technical success and clinical outcomes highlights one of the study’s key insights: A well-executed fixation does not necessarily translate into fewer complications in this age group.
Fracture pattern, timing, and surgeon expertise shape decision making
Despite these findings, Dr. Cantrell stopped short of recommending a universal treatment pathway. Instead, he emphasized that decision making remains inherently individualized. “You really need to do what you’re good at [doing],” he said, underscoring the importance of surgeon expertise. For surgeons experienced in hip arthroplasty, replacement may be a strong consideration; however, factors such as imaging findings and fracture characteristics also play a critical role. For instance, a fracture that can be anatomically reduced and stably fixed may still be a candidate for ORIF, while more complex or delayed presentations may favor arthroplasty, he explained.
Timing emerged as another important variable. Dr. Cantrell noted that some patients present several days after injury with substantial fracture comminution, making stable internal fixation more challenging and changing the treatment discussion. These differences reinforce the need for nuanced clinical judgment rather than a one-size-fits-all approach.
Fracture type also influenced treatment patterns within the study. The majority of fractures were transcervical, but a higher proportion of subcapital fractures were treated with arthroplasty. Subcapital fractures occur immediately below the femoral head, whereas basicervical fractures occur at the base of the femoral neck near the intertrochanteric region. Dr. Cantrell described subcapital fractures in younger patients as “a big problem,” noting the difficulty of achieving reliable fixation in these cases. Conversely, basicervical fractures were more commonly treated with ORIF, reflecting a degree of selection bias toward fractures deemed more amenable to fixation.
Additional nuances arise with impacted fractures, where bone fragments are driven into each other. Dr. Cantrell described a recent case involving a young patient with valgus impaction — where the femoral neck tilts outward — when surgeons opted not to correct the impaction to avoid destabilizing the fracture. However, greater degrees of valgus impaction may alter hip biomechanics and increase consideration of arthroplasty, depending on the overall clinical picture.
The study also touched on surgical technique. In the arthroplasty group, most procedures used anterior or anterolateral approaches, whereas about 25% used a posterior approach. No significant differences in outcomes were observed between these approaches. In the fixation group, surgeons used a variety of constructs, including sliding hip screws, cannulated screws, and a smaller number of cephalomedullary nails. However, the distribution of fixation constructs was too variable to draw meaningful comparisons.
Growing overlap between trauma and arthroplasty surgeons influences treatment decisions
An underlying theme in the discussion was the evolving overlap between trauma and arthroplasty surgery. While hip fractures are often managed by trauma surgeons, arthroplasty procedures may fall more within the expertise of joint reconstruction specialists. Dr. Cantrell acknowledged that in some cases, this could lead to transfer of care or short delays to allow a more experienced arthroplasty surgeon to perform the procedure.
“I do my own total hips. It’s something I’m comfortable doing. I do a good number of them, so I’m able to … have that conversation with patients, and a lot of my partners are the same way. … There’s more and more crossover as the years go by between trauma and hip arthroplasty,” he said, though he noted that surgeon comfort and availability still vary widely.
Long-term data needed
A major limitation of the study is its follow-up duration. Although the cohort was followed for a mean of approximately 76 weeks, patients were only required to have 12 weeks of follow-up for inclusion, and long-term implant survivorship remains unknown. This is particularly important in a population aged 40 to 49, where successful treatment must remain durable for decades.
“We’re talking about a 40- or 50-year lifespan for a hip replacement, which is maybe at the limit,” Dr. Green said. Dr. Cantrell acknowledged this concern and confirmed plans to follow patients at one, five, and 10 years to better understand long-term outcomes.
Ultimately, the study sheds light on a challenging clinical decision with no universally correct answer. While THA showed lower complication and reoperation rates in this cohort, the choice between arthroplasty and internal fixation remains highly dependent on patient characteristics, fracture patterns, and surgeon expertise. As longer-term data become available, the balance of evidence may shift — but for now, individualized care remains essential.
Theresa Witham is managing editor of AAOS Now.